Cloudnine to Invest Rs 400 Crore for expansion
CHENNAI: With the view of increasing demand of maternal care for women in India, Cloudnine, a Bengaluru-based maternity care hospital chain has announced that it is going to enter into preventive health management for women.
Hindu also reports that the company plans to invest Rs. 400 crore in coming year. Cloudnine plans to develop seven hospitals in Bengaluru, Delhi, Mumbai and Chandigarh by June 2018.The investment will be done in genetic profiling and other technology for women wellness.
An additional Rs. 150 crore will be spent on strengthening the Chennai market and expanding to newer markets such as Kochi, Visakhapatnam and Coimbatore.
Earlier, the company invested in Transmural Biotech, a Spanish company, for early screening of breast cancer.
Speaking with BuisnessLine over the increasing demand of mother and neo-natal care centres, Nitin Nag, Regional Director, Cloudnine Group of Hospitals said, India has lack of maternal healthcare centre and lack of services for mother and their newborn babies.
He further said that around four in every 200 deliveries result in complications. But many hospitals in India lack a dedicated facility such as neonatal intensive care unit to handle complications and physicians specialised in neonatal care . “So, we collaborate with other hospitals and share the facility on need basis."
“There are times when we have more babies from other hospitals in the unit than in-house babies," Nag added.
Talking more about their expansion and reason behind the high investment Nag told media that “Around 15 per cent of Indian population suffer from fertility issues. Earlier, people who seek fertility treatment were in the age group 27 to 35. Now, we are seeing people between 23 and 31 years coming for fertility treatment.”
Cloudnine Hospitals is a leading chain of maternity and childcare hospitals which currently operates in the cities Bengaluru, Chennai, Gurgaon, Mumbai and Pune, and has more than 30,000 deliveries to its credit.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd